|
|
|
|
| LEADER |
01944nmm a2200385 u 4500 |
| 001 |
EB001891786 |
| 003 |
EBX01000000000000001055135 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
200301 ||| eng |
| 100 |
1 |
|
|a Meghpara, Beeran
|
| 245 |
0 |
0 |
|a Infectious conjunctivitis
|h Elektronische Ressource
|c Beeran Meghpara
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2020, 2020
|
| 300 |
|
|
|a 1 streaming video file (25 min.)
|b color, sound
|
| 505 |
0 |
|
|a Bacterial conjunctivitis: less common than viral conjunctivitis in adults -- Treatment of bacterial conjunctivas: often started empirically -- Topical antibiotics should not be used to treat viral conjunctivitis -- Hyperacute gonococcal conjunctivitis can progress rapidly to involve the cornea: systemic treatment is essential -- Chlamydial conjunctivitis causes a chronic follicular conjunctivitis that is treated with systemic medication -- Blepharoconjunctivitis: a chronic conjunctivitis that requires concomitant treatment of the eyelids
|
| 653 |
|
|
|a Conjunctivitis, Bacterial / therapy
|
| 653 |
|
|
|a Conjunctiva / Diseases
|
| 653 |
|
|
|a Cornea / physiopathology
|
| 653 |
|
|
|a Ophthalmia Neonatorum
|
| 653 |
|
|
|a Blepharitis
|
| 653 |
|
|
|a Anti-Bacterial Agents / therapeutic use
|
| 653 |
|
|
|a Conjunctivitis, Viral / therapy
|
| 653 |
|
|
|a Cornea / Infections
|
| 653 |
|
|
|a Conjunctivitis / Treatment
|
| 653 |
|
|
|a Conjunctiva / physiopathology
|
| 653 |
|
|
|a Eye / Diseases
|
| 653 |
|
|
|a Conjunctivitis / therapy
|
| 653 |
|
|
|a Gonorrhea
|
| 653 |
|
|
|a Conjunctivitis, Inclusion / therapy
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a The biomedical & life sciences collection
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/4141
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|